Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Cell & Gene Therapy

Stem cell research and commercialization in China...

CARsgen Starts US Phase II Trial of CLDN18.2 CAR-T for Gastric Cancer

CANbridge Reports Data From Preclinical Test of Gene Therapy for Spinal Muscular Atrophy

Keymed and Rona Partner to Discover siRNA Drugs for Severe Kidney Disease

Gracell Announces Trial of FasTCAR Candidate in Autoimmune Diseases

Reforgene Biotech Completes $15 Million Pre-B Round for Gene Editing Drugs

ChinaBio Event
September 20-21 | Shanghai
September 25-26 | Digital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China